BiotechTube
tranScrip

tranScrip

Oxford, United Kingdom· Est.
transcrip-group.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2004, tranScrip is a private, UK-based consultancy firm offering end-to-end drug development and commercialization services to the pharmaceutical and biotechnology industries. The company operates on a services business model, providing flexible, bespoke solutions such as fractional Chief Medical Officer support, regulatory affairs, clinical development, pharmacovigilance, and market access. With a focus on strategic partnership, tranScrip leverages its deep therapeutic expertise to help clients maximize product value and accelerate timelines for patient benefit.

OncologyInfectious DiseasesImmunologyNeurologyRespiratoryRare Diseases

Technology Platform

Integrated pharmaceutical consultancy platform offering strategic expertise and operational execution across the drug development lifecycle, including fractional CMO support, regulatory affairs, clinical development, pharmacovigilance, and market access.

Opportunities

Growing demand from virtual/small biotech companies lacking full in-house development capabilities and from large pharma seeking flexible external expertise.
Expansion into supporting novel therapeutic modalities (e.g., cell/gene therapies) and further penetration into high-growth therapeutic areas like oncology and rare diseases.

Risk Factors

Dependence on key personnel and talent retention in a competitive market.
Vulnerability to downturns in biotech funding which reduce client spending on consultancy services.
Intense competition from both large global CROs and niche boutique firms.

Competitive Landscape

Operates in a crowded pharmaceutical services sector competing against large, full-service CROs (IQVIA, ICON, PPD) and smaller specialist consultancies. Differentiates through a highly bespoke, partnership-oriented model and deep integration with client teams, positioning itself as a strategic advisor rather than just a service provider.

More companies in United Kingdom →